Barriers and facilitators to the conduct of critical care research in low and lower-middle income countries: A scoping review.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 30 07 2021
accepted: 28 03 2022
entrez: 5 5 2022
pubmed: 6 5 2022
medline: 10 5 2022
Statut: epublish

Résumé

Improvements in health-related outcomes for critically ill adults in low and lower-middle income countries need systematic investments in research capacity and infrastructure. High-quality research has been shown to strengthen health systems; yet, research contributions from these regions remain negligible or absent. We undertook a scoping review to describe barriers and facilitators for the conduct of critical care research. We searched MEDLINE and EMBASE up to December 2021 using a strategy that combined keyword and controlled vocabulary terms. We included original studies that reported on barriers or facilitators to the conduct of critical care research in these settings. Two reviewers independently reviewed titles and abstracts, and where necessary, the full-text to select eligible studies. For each study, reviewers independently extracted data using a standardized data extraction form. Barriers and facilitators were classified along the lines of a previous review and based on additional themes that emerged. Study quality was assessed using appropriate tools. We identified 2693 citations, evaluated 49 studies and identified 6 for inclusion. Of the included studies, four were qualitative, one was a cross-sectional survey and one was reported as an 'analysis'. The total number of participants ranged from 20-100 and included physicians, nurses, allied healthcare workers and researchers. Barriers identified included limited funding, poor institutional & national investment, inadequate access to mentors, absence of training in research methods, limited research support staff, and absence of statistical support. Our review identified potential solutions such as developing a mentorship network, streamlining of regulatory processes, implementing a centralized institutional research agenda, developing a core-outcome dataset and enhancing access to low-cost technology. Our scoping review highlights important barriers to the conduct of critical care research in low and lower-middle income countries, identifies potential solutions, and informs researchers, policymakers and governments on the steps necessary for strengthening research systems.

Sections du résumé

BACKGROUND
Improvements in health-related outcomes for critically ill adults in low and lower-middle income countries need systematic investments in research capacity and infrastructure. High-quality research has been shown to strengthen health systems; yet, research contributions from these regions remain negligible or absent. We undertook a scoping review to describe barriers and facilitators for the conduct of critical care research.
METHODS
We searched MEDLINE and EMBASE up to December 2021 using a strategy that combined keyword and controlled vocabulary terms. We included original studies that reported on barriers or facilitators to the conduct of critical care research in these settings. Two reviewers independently reviewed titles and abstracts, and where necessary, the full-text to select eligible studies. For each study, reviewers independently extracted data using a standardized data extraction form. Barriers and facilitators were classified along the lines of a previous review and based on additional themes that emerged. Study quality was assessed using appropriate tools.
RESULTS
We identified 2693 citations, evaluated 49 studies and identified 6 for inclusion. Of the included studies, four were qualitative, one was a cross-sectional survey and one was reported as an 'analysis'. The total number of participants ranged from 20-100 and included physicians, nurses, allied healthcare workers and researchers. Barriers identified included limited funding, poor institutional & national investment, inadequate access to mentors, absence of training in research methods, limited research support staff, and absence of statistical support. Our review identified potential solutions such as developing a mentorship network, streamlining of regulatory processes, implementing a centralized institutional research agenda, developing a core-outcome dataset and enhancing access to low-cost technology.
CONCLUSION
Our scoping review highlights important barriers to the conduct of critical care research in low and lower-middle income countries, identifies potential solutions, and informs researchers, policymakers and governments on the steps necessary for strengthening research systems.

Identifiants

pubmed: 35511911
doi: 10.1371/journal.pone.0266836
pii: PONE-D-21-24699
pmc: PMC9071139
doi:

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0266836

Subventions

Organisme : Wellcome Trust
ID : WT215522/Z19/Z
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Trop Med Infect Dis. 2020 Mar 29;5(2):
pubmed: 32235362
N Engl J Med. 2021 Feb 11;384(6):497-511
pubmed: 33264556
PLoS Med. 2015 Feb 03;12(2):e1001784
pubmed: 25646629
Indian J Crit Care Med. 2018 Jan;22(1):20-26
pubmed: 29422728
BMC Infect Dis. 2017 Sep 11;17(1):616
pubmed: 28893183
BMJ Open. 2017 Oct 13;7(10):e017246
pubmed: 29030412
JAMA. 2021 Nov 9;326(18):1807-1817
pubmed: 34673895
Ann Intern Med. 2018 Oct 2;169(7):467-473
pubmed: 30178033
Int J Equity Health. 2018 Mar 22;17(1):37
pubmed: 29566721
Lancet Respir Med. 2014 May;2(5):380-6
pubmed: 24740011
Indian J Crit Care Med. 2016 Apr;20(4):216-25
pubmed: 27186054
Ann Am Thorac Soc. 2013 Aug;10(4):281-9
pubmed: 23952845
Wellcome Open Res. 2021 Jan 28;6:14
pubmed: 33604455
Am J Trop Med Hyg. 2020 Mar;102(3):494-496
pubmed: 31912776
J Intensive Care Soc. 2019 Aug;20(3):190-195
pubmed: 31447910
BMJ Glob Health. 2019 Jul 29;4(Suppl 6):e001289
pubmed: 31406600
Front Pediatr. 2017 Dec 22;5:277
pubmed: 29312909
Indian J Crit Care Med. 2017 Dec;21(12):811-818
pubmed: 29307960
Wellcome Open Res. 2020 Jul 30;5:182
pubmed: 33195819
SICOT J. 2019;5:41
pubmed: 31769752
Elife. 2020 Jul 07;9:
pubmed: 32633232
Curr Opin Crit Care. 2020 Oct;26(5):489-499
pubmed: 32773613
J Pain Symptom Manage. 2010 Jan;39(1):54-68
pubmed: 19892510
Br J Anaesth. 2018 Oct;121(4):813-821
pubmed: 30236243
J Neurosci Rural Pract. 2021 Jul;12(3):518-523
pubmed: 34295106
Glob Health Action. 2020 Dec 31;13(1):1846904
pubmed: 33373280
BMJ. 2008 Aug 07;337:a1035
pubmed: 18687726
Afr J Emerg Med. 2020;10(Suppl 1):S23-S28
pubmed: 33318898
Anaesthesia. 2019 Feb;74(2):143-146
pubmed: 30525200
Ann Glob Health. 2020 Oct 01;86(1):126
pubmed: 33042781

Auteurs

Bharath Kumar Tirupakuzhi Vijayaraghavan (BK)

Department of Critical Care Medicine, Apollo Hospitals, Chennai, India.

Ena Gupta (E)

Department of Pulmonary and Critical Care Medicine, Einstein Health Network, Philadelphia, Pennsylvania, United States of America.

Nagarajan Ramakrishnan (N)

Department of Critical Care Medicine, Apollo Hospitals, Chennai, India.

Abi Beane (A)

Mahidol-Oxford Tropical Research Unit, Bangkok, Thailand.

Rashan Haniffa (R)

Mahidol-Oxford Tropical Research Unit, Bangkok, Thailand.
Department of Anaesthesia and Critical Care Medicine, University College London, London, United Kingdom.

Nazir Lone (N)

Usher Institute, University of Edinburgh, Edinburgh, United Kingdom.

Nicolette de Keizer (N)

Department of Medical Informatics, Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.

Neill K J Adhikari (NKJ)

Interdepartmental Division of Critical Care Medicine, Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH